Publicaciones en colaboración con investigadores/as de Lawrence Berkeley National Laboratory (18)

2023

  1. Artificial intelligence-empowered cellular morphometric risk score improves prognostic stratification of cutaneous squamous cell carcinoma

    Clinical and Experimental Dermatology

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  3. Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy

    Frontiers in Oncology, Vol. 13

2022

  1. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  2. From Mouse to Human: Cellular Morphometric Subtype Learned From Mouse Mammary Tumors Provides Prognostic Value in Human Breast Cancer

    Frontiers in Oncology, Vol. 11

  3. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

2021

  1. Distinct clinical impact and biological function of angiopoietin and angiopoietin-like proteins in human breast cancer

    Cells, Vol. 10, Núm. 10

2018

  1. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy

    Molecular Oncology, Vol. 12, Núm. 6, pp. 883-895

  2. Supplementary data for the biological age linked to oxidative stress modifies breast cancer aggressiveness

    Data in Brief

  3. The biological age linked to oxidative stress modifies breast cancer aggressiveness

    Free Radical Biology and Medicine, Vol. 120, pp. 133-146

2017

  1. Revisiting the impact of age and molecular subtype on overall survival after radiotherapy in breast cancer patients

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach

    Genome Biology, Vol. 16, Núm. 1

2013

  1. C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes

    Epigenetics, Vol. 8, Núm. 6

2012

  1. Allele-specific deletions in mouse tumors identify Fbxw7 as germline modifier of tumor susceptibility

    PLoS ONE, Vol. 7, Núm. 2

  2. Multiple Novel Alternative Splicing Forms of FBXW7α Have a Translational Modulatory Function and Show Specific Alteration in Human Cancer

    PLoS ONE, Vol. 7, Núm. 11

2011

  1. Cancer evolution and individual susceptibility

    Integrative Biology, Vol. 3, Núm. 4, pp. 316-328

2010

  1. International network of cancer genome projects

    Nature, Vol. 464, Núm. 7291, pp. 993-998

2007

  1. Crosstalk between Aurora-A and p53: Frequent Deletion or Downregulation of Aurora-A in Tumors from p53 Null Mice

    Cancer Cell, Vol. 11, Núm. 2, pp. 161-173